Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis

Hum, RM, Ho, P, Nair, N et al. (8 more authors) (2023) Non-trough adalimumab and certolizumab drug levels associated with a therapeutic EULAR response in adherent patients with rheumatoid arthritis. Rheumatology, 62 (6). pp. 2090-2097. ISSN 1462-0324

Abstract

Metadata

Item Type: Article
Authors/Creators:
  • Hum, RM
  • Ho, P
  • Nair, N
  • Jani, M
  • Morgan, AW
  • Isaacs, JD
  • Wilson, AG
  • Hyrich, KL
  • Plant, D
  • Barton, A
  • BRAGGSS collaborators
Copyright, Publisher and Additional Information:

© The Author(s) 2022. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/)

Keywords: RA, serum drug levels, therapeutic response, certolizumab, adalimumab, TNF-α, inhibitors, adherence
Dates:
  • Published: June 2023
  • Published (online): 3 October 2022
  • Accepted: 17 September 2022
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds) > Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM) > Discovery & Translational Science Dept (Leeds)
Funding Information:
Funder
Grant number
NIHR National Inst Health Research
NIHR202395
NIHR National Inst Health Research
BRC
MRC (Medical Research Council)
R116825
Depositing User: Symplectic Publications
Date Deposited: 10 Nov 2022 12:56
Last Modified: 28 Jun 2023 15:13
Status: Published
Publisher: Oxford University Press
Identification Number: 10.1093/rheumatology/keac564
Related URLs:
Open Archives Initiative ID (OAI ID):

Export

Statistics